Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 27 of 27 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/20/24
End: 01/10/25
Due: 01/10/26
Phase: N/A
Priority: Normal
Start: 04/07/25
End: 04/07/26
Due: 04/07/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Relative to Subjects With Normal Hepatic Function | NCT06562946 | Abbisko Therapeutics Co, Ltd | user2@example.com | None | 2024-09-20 | 2025-01-10 | 2026-01-10 | - | - | 2025-07-14 |
| A Mass Balance Study of [14C]ABSK011 | NCT06896760 | Abbisko Therapeutics Co, Ltd | user2@example.com | None | 2025-04-07 | 2026-04-07 | 2027-04-07 | - | - | 2025-07-14 |